Adicet Bio, Inc. Common Stock, Capital Shares Reserved for Future Issuance
Adicet Bio, Inc. (ACET) had Common Stock, Capital Shares Reserved for Future Issuance of 3.42 million shares as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Equity › Stockholders' Equity Note
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-05
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 3.42M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 3.17M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 2.65M shares.
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 32.33M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance | Common Stock, Capital Shares Reserved for Future Issuance as first filed |
|---|---|---|
| 2026-06-30 | 3.42M shares 10-Q · filed 2026-08-05 | |
| 2026-03-31 | 3.17M shares 10-Q · filed 2026-05-13 | |
| 2025-12-31 | 2.65M shares 10-Q · filed 2026-08-05 | |
| 2025-09-30 | 32.33M shares 10-Q · filed 2025-11-05 | |
| 2025-06-30 | 32.33M shares 10-Q · filed 2025-08-07 | |
| 2025-03-31 | 32.36M shares 10-Q · filed 2025-05-06 | |
| 2024-12-31 | 1.70M shares 10-K · filed 2026-03-12 | 27.21M shares 10-K · filed 2025-03-06 |
| 2024-09-30 | 27.21M shares 10-Q · filed 2024-11-06 | |
| 2024-06-30 | 27.71M shares 10-Q · filed 2024-08-13 | |
| 2024-03-31 | 22.75M shares 10-Q · filed 2024-05-14 | |
| 2023-12-31 | 12.31M shares 10-K · filed 2025-03-06 | |
| 2023-09-30 | 12.38M shares 10-Q · filed 2023-11-08 | |
| 2023-06-30 | 12.42M shares 10-Q · filed 2023-08-09 | |
| 2023-03-31 | 12.42M shares 10-Q · filed 2023-05-09 | |
| 2022-12-31 | 9.27M shares 10-K · filed 2024-03-19 | |
| 2022-09-30 | 9.27M shares 10-Q · filed 2022-11-08 | |
| 2022-06-30 | 9.43M shares 10-Q · filed 2022-08-10 | |
| 2022-03-31 | 9.67M shares 10-Q · filed 2022-05-12 | |
| 2021-12-31 | 6.83M shares 10-K · filed 2023-03-15 | |
| 2021-09-30 | 7.41M shares 10-Q · filed 2021-11-10 | |
| 2021-06-30 | 7.52M shares 10-Q · filed 2021-08-12 | |
| 2021-03-31 | 6.06M shares 10-Q · filed 2021-05-17 | |
| 2020-12-31 | 5.67M shares 10-K · filed 2022-03-15 | |
| 2020-09-30 | 5.59M shares 10-Q · filed 2020-11-05 | |
| 2020-06-30 | 5.98M shares 10-Q · filed 2020-07-30 | |
| 2020-03-31 | 5.98M shares 10-Q · filed 2020-05-07 | |
| 2019-12-31 | 14.83M shares 10-K · filed 2021-03-12 | 4.16M shares 10-K · filed 2020-03-12 |
| 2019-09-30 | 4.16M shares 10-Q · filed 2019-11-05 | |
| 2019-06-30 | 4.16M shares 10-Q · filed 2019-08-14 | |
| 2019-03-31 | 4.18M shares 10-Q · filed 2019-05-15 | |
| 2018-12-31 | 2.77M shares 10-K · filed 2020-03-12 | |
| 2018-09-30 | 2.78M shares 10-Q · filed 2018-11-13 | |
| 2018-06-30 | 2.78M shares 10-Q · filed 2018-08-09 | |
| 2018-03-31 | 2.78M shares 10-Q · filed 2018-05-10 | |
| 2017-12-31 | 17.74M shares 10-K · filed 2019-03-18 | |
| 2016-12-31 | 0.00 shares 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |